Home Cart Sign in  
Chemical Structure| 102-37-4 Chemical Structure| 102-37-4

Structure of Ethyl Caffeate
CAS No.: 102-37-4

Chemical Structure| 102-37-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ethyl caffeate shows suppressesion of NF-κB activation and its downstream inflammatory mediators. It can be found in bidens pilosa.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ethyl Caffeate

CAS No. :102-37-4
Formula : C11H12O4
M.W : 208.21
SMILES Code : O=C(OCC)/C=C/C1=CC=C(O)C(O)=C1
MDL No. :MFCD00045754
InChI Key :WDKYDMULARNCIS-GQCTYLIASA-N
Pubchem ID :5317238

Safety of Ethyl Caffeate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P264-P270-P301+P312-P330-P501

Related Pathways of Ethyl Caffeate

pyroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
RAW 264.7 macrophages 0.5-5 μg/ml 6 hours Inhibited iNOS mRNA and protein expression Br J Pharmacol. 2005 Oct;146(3):352-63
MCF-7 cells 10-100 μg/ml 6 hours Inhibited TPA-induced cox-2 transcriptional activity Br J Pharmacol. 2005 Oct;146(3):352-63
RAW264.7 cells 100 μM 2 hours Inhibited LPS-induced HMGB-1 protein secretion Molecules. 2011 Nov 10;16(11):9451-66
RAW 264.7 macrophages 0.1-20 μg/ml 24 hours Inhibited LPS-induced NO production, IC50=5.5 μg/ml Br J Pharmacol. 2005 Oct;146(3):352-63
Mouse bone marrow-derived mast cells (BMMCs) 10 μM 24 hours To evaluate the inhibitory effects of EC on DHNA-induced IL-6 production, results showed that EC inhibited DHNA-induced IL-6 production Int J Mol Sci. 2023 Jun 10;24(12):9997
Mouse bone marrow-derived mast cells (BMMCs) 1 or 10 μM 12 hours To evaluate the inhibitory effects of EC on AhR protein downregulation, results showed that EC inhibited FICZ-induced downregulation of AhR protein levels Int J Mol Sci. 2023 Jun 10;24(12):9997
Mouse bone marrow-derived mast cells (BMMCs) 1 or 10 μM 2 hours To evaluate the inhibitory effects of EC on AhR target gene expression, results showed that EC inhibited FICZ- or DHNA-induced Cyp1A1 mRNA expression Int J Mol Sci. 2023 Jun 10;24(12):9997
HeXS34 reporter cells 10 μM 12 hours To evaluate the inhibitory effects of EC on AhR activation, results showed that EC significantly inhibited FICZ- or DHNA-induced SEAP activity Int J Mol Sci. 2023 Jun 10;24(12):9997
BALB/c splenocytes 10 μM 48 hours To assess the effect of ECF on LPS-induced B cell proliferation, ECF inhibits B cell proliferation at 10 μM J Immunol Res. 2017;2017:7416792
Purified T cells 0.1, 1, 10 μM 48 hours To assess the effect of ECF on TCR crosslinking-mediated T cell proliferation, ECF significantly inhibits T cell proliferation J Immunol Res. 2017;2017:7416792
BALB/c splenocytes 0.1, 1, 10 μM 48 hours To assess the immunosuppressive effect of ECF in vitro, ECF significantly inhibits ConA-induced murine splenocyte proliferation J Immunol Res. 2017;2017:7416792
HCC827OR cells 82 µM 48 hours Inhibited migration and proliferation of HCC827OR cells, promoted apoptosis, and downregulated MET expression Cancer Cell Int. 2025 Mar 15;25(1):99
PC9OR cells 78 µM 48 hours Inhibited migration and proliferation of PC9OR cells, promoted apoptosis, and downregulated MET expression Cancer Cell Int. 2025 Mar 15;25(1):99
RAW264.7 cells 75, 150, 300, 500 nM 2 hours To investigate the effect of Ethyl Caffeate on NO production in LPS-induced RAW264.7 cells, results showed that Ethyl Caffeate significantly reduced extracellular NO levels. Front Pharmacol. 2022 Feb 23;13:801350
RAW264.7 cells 20, 50, 100 μM 2 hours Inhibited LPS-induced iNOS, IL-1β, and IL-10 mRNA expression Molecules. 2011 Nov 10;16(11):9451-66

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Passive cutaneous anaphylaxis (PCA) model Oral 10 mg/kg Single dose, evaluated after 24 hours To evaluate the inhibitory effects of EC on PCA reaction, results showed that EC significantly inhibited ear swelling, Evans blue dye extravasation, and serum MCP-1 levels Int J Mol Sci. 2023 Jun 10;24(12):9997
DBA/1 mice Collagen-induced arthritis model Oral 50 mg/kg Once daily for 10 days To investigate the antiarthritic potential of ECF, ECF treatment reduced the severity of CIA, inhibited IFN-γ and IL-6 secretion, and decreased the proportion of CD11b+Gr-1+ splenic neutrophil J Immunol Res. 2017;2017:7416792

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.80mL

0.96mL

0.48mL

24.01mL

4.80mL

2.40mL

48.03mL

9.61mL

4.80mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories